Efficacy of clomifen citrate in Natural Cycle IVF

Efficacy of clomifen citrate in Natural Cycle IVF - Clomifen stimulation in Natural Cycle IVF

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005137

Enrollment

100

Registered

2013-07-26

Start date

2012-10-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N97

Interventions

Group 1: 1st cycle: Natural Cycle IVF without clomifen citrate Group 2: 2nd cycle (if no pregnancy in the 1st IVF cycle): Natural Cycle IVF with clomifen citrate: start clomifen citrate day on 6th or

Eligibility

Sex/Gender

Female

Age

18 Years to 42 Years

Inclusion criteria

Inclusion criteria: Indication for an IVF therapy, wish of the patient to undergo an Natural Cycle IVF-therapy, regular menstruations (26-30 days), age 18-42

Exclusion criteria

Exclusion criteria: Irregular Menstruations Age >42 years

Design outcomes

Primary

Measure	Time frame
Pregnancy rate per treatment cycle	—

Secondary

Measure	Time frame
Premature ovulation rate, number of oocytes per cycle, transfer rate per cycle, pregnancy rate per transfer	—

Countries

Switzerland

Contacts

Public ContactMichael von Wolff

Abteilung Gynäkologische Endokrinologie und Reproduktionsmedizin

Michael.vonWolff@insel.ch0041-31-6321301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026